About StemCellor

Medical coordination for patients considering treatment in Japan.

StemCellor is a Japan-based medical coordination service for international patients considering regenerative, aesthetic, and longevity medicine in Japan. We organize information, not outcomes — every treatment decision is confirmed case by case by a licensed physician.

Who we are

StemCellor was built for a specific, recurring problem: patients considering regenerative, aesthetic, or longevity medicine in Japan are often surrounded by information, yet still lack a trustworthy, practical starting point. Marketing claims, fragmented clinic materials, regulatory terminology, unclear pricing, and language barriers can make it difficult to understand which options are worth discussing, what may be medically unsuitable, and what a realistic visit to Japan would actually require.

We are a coordination service, not a treatment provider. We do not diagnose, and we do not perform any medical procedure ourselves. Our role is to turn a scattered set of questions, records, goals, budget expectations, and travel constraints into a clear case file that a licensed physician or medical institution in Japan can review efficiently. This helps reduce repeated explanations, avoid poorly matched inquiries, clarify likely cost and timeline considerations earlier, and make the path toward physician review more focused and practical.

What we coordinate

Concretely, this is what a StemCellor engagement looks like in practice.

An international patient and coordinator preparing records and travel documents together
01

Medical record organization

We help you assemble your relevant history, current medications, prior test results, and treatment goals into a format a physician can review efficiently.

02

Treatment pathway explanation

We explain, in plain language, what regenerative, aesthetic, and longevity treatments in Japan typically involve — process, timeline, and regulatory context — before you commit to anything.

03

Case-by-case physician review

We coordinate the review of your case with licensed physicians and medical institutions in Japan. The physicians involved may be external to StemCellor and are confirmed individually, not from a fixed roster.

04

Appointment and visit planning

Once a physician has reviewed your case, we help coordinate consultation timing, visit scheduling, and the logistics of traveling to Japan.

05

Multilingual communication

Coordination is available in English, Japanese, and Mandarin, so language is not a barrier between you and the physician reviewing your case.

Selected institutional pathway

For appropriate international enquiries, we may coordinate planning and communication with selected regenerative medicine providers in Japan.

01
Fukuoka, Japan

Kyushu Regenerative Medicine Center

Kyushu Regenerative Medicine Center publicly describes a regenerative medicine clinic, cell-processing center, and rehabilitation center. For enquiries that are appropriate to take further, StemCellor may help coordinate an initial planning route with the institution.

Where the receiving provider can offer programme-specific conditions, we can help discuss case-by-case fee options. Availability, medical suitability, and any written quote are confirmed directly by the receiving provider.

Visit the institution website

StemCellor does not own or operate this institution. Its inclusion does not imply an exclusive relationship or guarantee access, preferential pricing, or treatment.

Representative Scenarios

Patient situations we help clarify

These are composite planning scenarios, not real patient testimonials. They reflect common questions international patients bring before physician review.

What we do not promise

Being direct about this is part of how we work — not a disclaimer buried in fine print.

01

We do not diagnose any condition. Diagnosis is made only by a licensed physician.

02

We do not guarantee treatment eligibility. Candidacy is confirmed individually, and some prospective patients are advised to delay or not proceed.

03

We do not guarantee treatment outcomes. No specific result is promised for any treatment.

04

We do not guarantee access to a specific, named physician. Physicians are confirmed case by case based on medical suitability and availability.

05

We do not claim to hold an MHLW regenerative medicine provision plan acceptance number ourselves unless a real, confirmed number is published on this site.

06

We do not own or operate a clinic, hospital, or cell-processing facility. Treatment is provided by licensed Japanese physicians and medical institutions, confirmed case by case.

Why Japan

Japan regulates regenerative medicine under the Act on the Safety of Regenerative Medicine, which classifies treatments by risk and requires review by a certified regenerative medicine committee before provision begins. This framework is a review of process, not a guarantee of any individual outcome — but it is a genuine, structural reason patients look to Japan specifically.

StemCellor's role is to help you navigate that framework as an international patient: understanding which category applies, what a physician will need to review, and what a realistic timeline looks like — before you book a flight.

Read Our Safety & Regulation Overview

How it works

A private case review always comes before any plan, quote, or travel arrangement.

01
Share your background
Send your main concern, treatment goals, and relevant medical history through a private case review.
02
We organize your case
Our coordination team prepares your information into a format a physician can review, and identifies which type of consultation may be appropriate.
03
Physician review is arranged
A licensed physician reviews your case and confirms candidacy — this may result in a proposed plan, a request for more information, or a recommendation to delay or not proceed.
04
Plan and travel are confirmed
Only after physician review are treatment plans, reference costs, and travel logistics finalized together with you.

Trust principles

The standards we hold ourselves to, stated plainly rather than left implicit.

Physician judgment first
No treatment plan is proposed until a licensed physician has reviewed your case. Coordination follows medical judgment, not the other way around.
No invented claims
We do not publish doctor names, hospital affiliations, regulatory numbers, or partnerships that have not been independently confirmed.
Transparent, published pricing
Reference pricing is published openly on this site rather than held back behind a contact form — details are confirmed individually, not withheld as leverage.
Honest about limits
A genuine case review can end in "not yet" or "not recommended." We treat that as a normal, expected outcome, not a failure of service.

Editorial standards

How Journal content is prepared, sourced, and kept current — stated plainly, the same way we state what we do and do not promise.

How content is prepared
Journal articles are prepared by StemCellor's editorial team, using publicly available regulatory sources, peer-reviewed research, and information already confirmed elsewhere on this site. Articles are written to explain a topic clearly, not to promote a specific treatment.
How sources are chosen
Where an article makes a specific factual or research-based claim, we link directly to the peer-reviewed study, official regulatory text, or government source it relies on. A claim that cannot be traced to a citable source is written as a general statement, not presented as backed by research it isn't.
What we do and do not claim
We do not describe Journal content as reviewed or approved by a physician unless a named, verified reviewer is actually attached to that specific article. Where no such review exists, the article is presented as general information prepared by our editorial team — not as clinical guidance.
How updates are handled
Content is not published once and left unchanged. When a cited source is updated, a regulatory framework changes, or an inaccuracy is identified, the published article is corrected directly rather than left as an outdated snapshot.
Who is responsible
StemCellor's editorial team is responsible for the accuracy and framing of everything published in the Journal. Where the evidence is uncertain or incomplete, articles say so directly rather than implying more certainty than the underlying research supports.
About StemCellor

Start with a review, not a reservation.

Share your background and goals. StemCellor will help organize the next step around physician review, realistic expectations, and reference cost — before anything is booked.

Private Case Review

Let us understand the case before anyone recommends a plan.

Share your goals, medical background, and travel window. StemCellor will help organize the next step around physician review, realistic expectations, timing, and reference cost.

Direct messaging channels are still being confirmed — for now, start through the international patient guide.

A private review table with a tea cup, closed folio, and folded documents in a quiet Japanese interior
Prepare an Inquiry
01
Share your background

Send the main concern, treatment goals, and any medical history that may affect candidacy.

02
Review the right pathway

We help clarify which treatment area may be worth discussing before travel is planned.

03
Coordinate the next step

When appropriate, the case is prepared for physician review and visit planning in Japan.

Open consultation chat